Amy Visit 2: A 16-Year-Old Girl With Depression and Hypersomnia

Title:	Amy Visit 2: A 16-Year-Old Girl With Depression and Hypersomnia
Topic:	Psychiatry
Relevant Terms:	Adolescent, Major Depressive Disorder, Mood Disorders
Primary Audience:	Family Physicians, Pediatricians, Psychiatrists
Launch Date:	26-May-11
Credits:	0.5 AMA PRA Category 1 Credit™
Expiration Date:	The accreditation for this activity has expired.
Curriculum Name:	Diagnosis and Treatment of Adolescent Depression

Enter this activity!

Learning Objectives

Upon completion of the activity, participants should be able to:

Employ evidence-based strategies in the selection and use of antidepressants when treating depression in special populations
Implement individualized treatment plans for patients with depression that maximize outcomes

Faculty

Ronnie G. Swift, MD
Professor and Associate Chairman, Department of Psychiatry and Behavioral Sciences,
New York Medical College, Valhalla
Professor of Clinical Public Health, School of Public Health, New York; New York Medical College, Valhalla
Chief of Psychiatry and Associate Medical Director, Metropolitan Hospital Center, New York City

Ronnie G. Swift, MD

Dr. Ronnie Gorman Swift is a 1969 graduate of the City College of New York, where she majored in Chemistry, graduating with honors. She attended the University of North Carolina School of Medicine where she was elected to AOA, the Medical Honor Society, and received the George C. Thrasher, Jr. Award "given annually to that member of the graduating class who during his/her medical school experience has shown most outstanding performance and ability in Psychiatry." During her residency at the University of North Carolina Hospital, she was selected by the American Psychiatric Association as one of 15 psychiatry residents nationally to receive a Falk Fellowship. The Falk Fellowship program recognized "a unique leadership group of physicians in psychiatric residency training." As part of this fellowship, Dr. Swift served on the APA Program Committee for two years.

In March of 2009 Dr. Swift was honored by Metropolitan Hospital during women's history week for her outstanding contributions to the hospital. Dr. Swift is included in Who's Who in America, Who's Who in the World and received America's Top Psychiatric Award given by Consumers' Research Council of America.

In September 2005, Dr. Swift was awarded Honorary Membership in the World Psychiatric Association for her "contributions to Psychiatry." In May 2005, New York Medical College selected Dr. Swift as the first recipient of the Sidney E. Frank Visiting Professor Award. This program establishes a visiting professor exchange program between New York Medical College and Hadassah University in Israel. In June 2005, Dr. Swift received the Teacher of the Year Award and in June 2004, she received an award for her Teaching and Leadership in the Psychiatry Residency at Metropolitan Hospital Center. In April 2004, Dr. Swift co-chaired the Scientific Program Committee for the World Psychiatric Association Meeting held at Metropolitan Hospital Center.

Dr. Swift chairs and serves on numerous clinical committees and task forces for New York Medical College, New York City Health and Hospitals Corporation, New York City Department of Health and Metropolitan Hospital Center to improve patient care, patient safety and to establish best practices. She has helped develop guidelines for best practice on topics including Psychiatric Assessment in the Emergency Room, Suicide Risk Assessment, Methadone Treatment, Detoxification Treatment, Integrating Depression Screening in Primary Care, and Developing a Culture of Patient Safety to name a few. Dr. Swift is a frequent invited speaker on topics as varied as Diagnosing and Treating Depression in Primary Care, Treating Tobacco Addiction in Psychiatric Patients, Diagnosis and Treatment of Psychiatric Illness in Different Ethnic and Racial Groups, Comprehensive Health and Integration of Services, Current Treatment Options for Bipolar Disorder, the Use of Atypical Antipsychotics, Treating Depression During Pregnancy and Using Genetic History in the Diagnosis of Psychiatric Illness.

Dr. Swift has done research on the Wolfram Syndrome since 1980 and is considered an expert on the clinical manifestations of this disorder.

Thomas Schwartz, MD
Associate Professor, Department of Psychiatry,
SUNY Upstate Medical University, Syracuse, NY

Stephen M. Stahl, MD, PhD
Adjunct Professor, Department of Psychiatry, University of California, San Diego School of Medicine
Honorary Visiting Senior Fellow, University of Cambridge, UK

Stephen M. Stahl, MD, PhD

Dr. Stephen M. Stahl received his undergraduate and medical degrees from Northwestern University in Chicago, as a member of the Honors Program in Medical Education and his Ph.D. in pharmacology and physiology from the University of Chicago. Dr. Stahl has trained in three specialties: internal medicine at the University of Chicago; neurology at the University of California in San Francisco; and psychiatry at Stanford University. He is board certified in psychiatry.

Dr. Stahl has held faculty positions at Stanford University, the University of California at Los Angeles, the Institute of Psychiatry London, and the Institute of Neurology London, and he currently holds a faculty position at the University of California at San Diego. Recently, Dr. Stahl was elected an Honorary Visiting Senior Fellow in the Department of Psychiatry at the University of Cambridge in the UK. Dr. Stahl was also Executive Director of Clinical Neurosciences at the Merck Neuroscience Research Center in the UK for several years. Dr. Stahl's major interests are producing and disseminating educational information about diseases and their treatments in psychiatry and neurology, with a special emphasis on multimedia, the Internet and teaching how to teach.

Dr. Stahl has conducted numerous research projects awarded by the National Institute of Mental Health, the Veterans Administration, and the pharmaceutical industry. Author of over 400 articles and chapters and more than 1200 scientific presentations and abstracts, Dr. Stahl is an internationally recognized clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has edited 5 books and written more than 25 others, including the best-selling and award-winning textbook, Stahl's Essential Psychopharmacology, now in its third edition; the best-selling and award-winning clinical manual, Stahl's Essential Psychopharmacology: Prescriber's Guide, now in its fourth edition; and the recently published book of clinical cases, Case Studies: Stahl's Essential Psychopharmacology.

Lectures, courses, and preceptorships based on his textbooks have taken him to dozens of countries on 6 continents to speak to tens of thousands of physicians, mental health professionals, and students at all levels. His lectures and scientific presentations have been distributed as more than a million CD-ROMs, Internet educational programs, videotapes, audiotapes, and programmed home study texts for continuing medical education to hundreds of thousands of professionals in many different languages. His courses and award-winning multimedia teaching materials are used by psychopharmacology teachers and students throughout the world. Dr. Stahl also writes didactic features for mental health professionals in numerous journals.

Dr. Stahl is a fellow of the ACNP (American College of Neuropsychopharmacology) and the CINP (Collegium Internationale Neuro-Psychopharmacologicum), where he was formerly vice president. He serves as associate editor of Acta Psychiatrica Scandinavica, is former clinical field editor for the International Journal of Neuropsychopharmacology and is on numerous editorial boards of other leading journals including the ACNP's journal Neuropsychopharmacology. He also serves on numerous medical and scientific advisory boards for the pharmaceutical industry, the biotechnology and medical information industry, and various nonprofit and public service organizations, including appointment by the State of California as current Chair of the Medi-Cal Oversight Board for Medicines (Drug Utilization Review Board).

His educational research programs are monitoring changes in diagnosing and prescribing behaviors as outcomes from various educational interventions for programs organized by the Neuroscience Education Institute, which he chairs. He also has an active clinical practice specializing in psychopharmacologic treatment of resistant cases.

He has been named recipient of the International College of Neuropsychopharmacology (CINP) Lundbeck Foundation Award in Education for his contributions to postgraduate education in psychiatry and neurology, and also the winner of the A.E. Bennett Award of the Society of Biological Psychiatry, the American Psychiatric Association/San Diego Psychiatric Society Education Award and has been cited as both one of "America's Top Psychiatrists" and one of the "Best Doctors in America."

Adam M. Brenner, MD
Advisor/Content Peer Reviewer
Associate Professor
Director of Residency Training in Psychiatry
Director of Medical Student Education in Psychiatry
The University of Texas Southwestern Medical Center, Dallas, TX

TARGET AUDIENCE

This activity has been developed for clinicians specializing in psychiatry. There are no prerequisites. All health care providers interested in psychopharmacology, especially primary care physicians, nurses, psychologists, and pharmacists, are welcome for advanced study.

DISCLAIMER

Information and opinion offered by the speakers represent their viewpoints. Conclusions drawn by the audience should be derived from careful consideration of all available scientific information. Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be "off-label" use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.

DISCLOSURE POLICY STATEMENT

It is the policy of The University of Texas Southwestern Medical Center Office of Continuing Medical Education to ensure balance, independence, objectivity, and scientific rigor in all directly sponsored and jointly sponsored educational activities. All participants in certified CME activities should be made aware of any affiliation or financial interest that may affect the speaker's presentation(s). Each speaker has completed and signed a conflict of interest disclosure form. The faculty members' relationships are outlined below.

Stephen M. Stahl, MD, PhD

Grant/Research: AstraZeneca, BioMarin, Dainippon Sumitomo, Forest, GenOmind, Lilly, Merck, Novartis, Pamlab, Pfizer, PGxHealth/Clinical Data, Schering-Plough, Sepracor, Servier, Shire, and Torrent.

Consultant/Advisor: Advent, Alkermes, Allergan, Arena, AstraZeneca, BioMarin, Boehringer Ingelheim, Bristol-Myers Squibb, Cypress Bioscience, Dainippon Sumitomo, Eisai, Forest, GenOmind, Janssen Division of Ortho-McNeil-Janssen, Jazz, Labopharm, Lilly, Lundbeck, Meiji, Merck, Neuronetics, Novartis, Orexigen, Otsuka America, Pamlab, Pfizer, PGxHealth/Clinical Data, Rexahn, Royalty, Schering-Plough, Servier, Shire, and VIVUS.

Speakers Bureau: Dainippon Sumitomo, Lilly, Merck, Pamlab, Sepracor, and Sunovion.

Thomas Schwartz, MD

Grant/Research: Cephalon, Inc.; Cyberonics; Forest Laboratories, Inc.; Forest Pharmaceuticals, Inc.

Consultant/Advisor: Pamlab, L.L.C.

Speakers Bureau: AstraZeneca Pharmaceuticals LP (divested); Pfizer Inc (divested); Wyeth Pharmaceuticals (divested)

Ronnie G. Swift, MD

Nothing to disclose.

Adam M. Brenner, MD

Nothing to disclose.

Planning Committee Members

Richard Vanderpool, CCMEP

Sr. Continuing Education Coordinator

University of Texas Southwestern Medical Center

Nothing to disclose.

Rory Daly, MPH

Associate Director, Program Development

Neuroscience Education Institute

Nothing to disclose.

Steve Smith

President and COO

Neuroscience Education Institute

Nothing to disclose.

CREDIT DESIGNATION

The University of Texas Southwestern Medical Center designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCREDITATION STATEMENT

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

HOW TO RECEIVE CREDIT

By reviewing the course content and successfully completing the posttest and evaluation, physicians are entitled to receive 0.5 AMA PRA Category 1 Credit™. Statements of credit will be available to print from your user history page.

Read the learning objectives and faculty disclosures.
Participate in the activity.
Complete the posttest and activity evaluation.
Physicians who successfully complete the posttest and evaluation will receive CME credit. You must score 70% or higher on the posttest to receive credit for this activity.
All other participants who successfully complete the posttest and evaluation will receive a certificate of participation.

COURSE VIEWING REQUIREMENTS

PC
Internet Explorer (v6 or greater) or Firefox

MAC
Safari

Release Date: May 25, 2011

Expiration Date: May 24, 2012

COMMERCIAL SUPPORT

This activity is being supported by an educational grant from Pfizer Inc.

This continuing medical education activity is provided by The University of Texas Southwestern Medical Center in collaboration with RealCME and the Neuroscience Education Institute.

Enter this activity!